Cytokinetics Inc (CYTK) Event Aug. 01, 2022, 13:01 UTC 98 0 comments Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Comment Full text
EAGLE PHARMS INC (EGRX) Event Aug. 01, 2022, 12:31 UTC 17 1 comments (99% Neutral) Eagle Pharmaceuticals, Inc. (EGRX) Announces Regulatory Update Comment Full text
OncoCyte Corporation (OCX) Event Aug. 01, 2022, 12:05 UTC 19 1 comments (94% Neutral) Oncocyte Corporation (OCX) Announces Clinical Development Update Comment Full text
Chimerix Inc (CMRX) Event Aug. 01, 2022, 11:54 UTC 18 1 comments (70% Positive) Chimerix, Inc. (CMRX) Announces Business Combination Comment Full text
HUTCHMED DRC (HCM) Event Aug. 01, 2022, 11:33 UTC 15 1 comments (10% Negative) HUTCHMED DRC (HCM) Reports Q2 2022 Financial Results (Form 6-K) Comment Full text
ATAI Life Sciences (ATAI) Event Aug. 01, 2022, 11:31 UTC 18 1 comments (99% Neutral) ATAI LIFE SCIENCES N.V. (ATAI) Announces Business Combination Comment Full text
ObsEva SA (company was delisted NASDAQ) (OBSV) Event Aug. 01, 2022, 11:21 UTC 15 1 comments (99% Neutral) ObsEva SA (company was delisted NASDAQ) (OBSV) Announces Clinical Development Update (Form 6-K) Comment Full text
Tonix Pharmaceuticals Holding Corp (TNXP) Event Aug. 01, 2022, 11:07 UTC 17 1 comments (99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update Comment Full text
TherapeuticsMD Inc (TXMD) Event Aug. 01, 2022, 10:55 UTC 17 1 comments (35% Negative) TherapeuticsMD, Inc. (TXMD) Announces Business Combination Comment Full text
HUTCHMED DRC (HCM) Event Aug. 01, 2022, 10:53 UTC 14 1 comments (99% Neutral) HUTCHMED DRC (HCM) Announces Clinical Development Update (Form 6-K) Comment Full text